Matches in Nanopublications for { <http://www.w3.org/1999/02/22-rdf-syntax-ns#OBJECT> ?p ?o ?g. }
- OBJECT label "mortality in COVID-19 patients in hospital" provenance.
- OBJECT label "significantly, in 2020, in comparison to 2019 ( p < 0.0001 for urgent and elective surgeries and 0.01 for intravitreal injections )" provenance.
- OBJECT label "significantly, in 2020, in comparison to 2019 ( p < 0.0001 for urgent and elective surgeries and 0.01 for intravitreal injections )" provenance.
- OBJECT label "significantly, in 2020, in comparison to 2019 ( p < 0.0001 for urgent and elective surgeries and 0.01 for intravitreal injections )" provenance.
- OBJECT label "significantly, in 2020, in comparison to 2019 ( p < 0.0001 for urgent and elective surgeries and 0.01 for intravitreal injections )" provenance.
- OBJECT label "significantly, in 2020, in comparison to 2019 ( p < 0.0001 for urgent and elective surgeries and 0.01 for intravitreal injections )" provenance.
- OBJECT label "significantly, in 2020, in comparison to 2019 ( p < 0.0001 for urgent and elective surgeries and 0.01 for intravitreal injections )" provenance.
- OBJECT label "significantly, in 2020, in comparison to 2019 ( p < 0.0001 for urgent and elective surgeries and 0.01 for intravitreal injections )" provenance.
- OBJECT label "significantly, in 2020, in comparison to 2019 ( p < 0.0001 for urgent and elective surgeries and 0.01 for intravitreal injections )" provenance.
- OBJECT label "significantly, in 2020, in comparison to 2019 ( p < 0.0001 for urgent and elective surgeries and 0.01 for intravitreal injections )" provenance.
- OBJECT label "significantly, in 2020, in comparison to 2019 ( p < 0.0001 for urgent and elective surgeries and 0.01 for intravitreal injections )" provenance.
- OBJECT label "significantly, in 2020, in comparison to 2019 ( p < 0.0001 for urgent and elective surgeries and 0.01 for intravitreal injections )" provenance.
- OBJECT label "significantly, in 2020, in comparison to 2019 ( p < 0.0001 for urgent and elective surgeries and 0.01 for intravitreal injections )" provenance.
- OBJECT label "significantly, in 2020, in comparison to 2019 ( p < 0.0001 for urgent and elective surgeries and 0.01 for intravitreal injections )" provenance.
- OBJECT label "significantly, in 2020, in comparison to 2019 ( p < 0.0001 for urgent and elective surgeries and 0.01 for intravitreal injections )" provenance.
- OBJECT label "significantly, in 2020, in comparison to 2019 ( p < 0.0001 for urgent and elective surgeries and 0.01 for intravitreal injections )" provenance.
- OBJECT label "significantly, in 2020, in comparison to 2019 ( p < 0.0001 for urgent and elective surgeries and 0.01 for intravitreal injections )" provenance.
- OBJECT label "significantly, in 2020, in comparison to 2019 ( p < 0.0001 for urgent and elective surgeries and 0.01 for intravitreal injections )" provenance.
- OBJECT label "significantly, in 2020, in comparison to 2019 ( p < 0.0001 for urgent and elective surgeries and 0.01 for intravitreal injections )" provenance.
- OBJECT label "significantly, in 2020, in comparison to 2019 ( p < 0.0001 for urgent and elective surgeries and 0.01 for intravitreal injections )" provenance.
- OBJECT label "significantly, in 2020, in comparison to 2019 ( p < 0.0001 for urgent and elective surgeries and 0.01 for intravitreal injections )" provenance.
- OBJECT label "the effect of the ensuing cytokine storm in critically ill patients COVID-19" provenance.
- OBJECT label "the effect of the ensuing cytokine storm in critically ill patients COVID-19" provenance.
- OBJECT label "the effect of the ensuing cytokine storm in critically ill patients COVID-19" provenance.
- OBJECT label "the effect of the ensuing cytokine storm in critically ill patients COVID-19" provenance.
- OBJECT label "the effect of the ensuing cytokine storm in critically ill patients COVID-19" provenance.
- OBJECT label "the effect of the ensuing cytokine storm in critically ill patients COVID-19" provenance.
- OBJECT label "the effect of the ensuing cytokine storm in critically ill patients COVID-19" provenance.
- OBJECT label "the effect of the ensuing cytokine storm in critically ill patients COVID-19" provenance.
- OBJECT label "the effect of the ensuing cytokine storm in critically ill patients COVID-19" provenance.
- OBJECT label "the effect of the ensuing cytokine storm in critically ill patients COVID-19" provenance.
- OBJECT label "the effect of the ensuing cytokine storm in critically ill patients COVID-19" provenance.
- OBJECT label "the effect of the ensuing cytokine storm in critically ill patients COVID-19" provenance.
- OBJECT label "the effect of the ensuing cytokine storm in critically ill patients COVID-19" provenance.
- OBJECT label "the effect of the ensuing cytokine storm in critically ill patients COVID-19" provenance.
- OBJECT label "the effect of the ensuing cytokine storm in critically ill patients COVID-19" provenance.
- OBJECT label "the effect of the ensuing cytokine storm in critically ill patients COVID-19" provenance.
- OBJECT label "the effect of the ensuing cytokine storm in critically ill patients COVID-19" provenance.
- OBJECT label "the effect of the ensuing cytokine storm in critically ill patients COVID-19" provenance.
- OBJECT label "the effect of the ensuing cytokine storm in critically ill patients COVID-19" provenance.
- OBJECT label "the effect of the ensuing cytokine storm in critically ill patients COVID-19" provenance.
- OBJECT label "the effect of the ensuing cytokine storm in critically ill patients COVID-19" provenance.
- OBJECT label "the effect of the ensuing cytokine storm in critically ill patients COVID-19" provenance.
- OBJECT label "the effect of the ensuing cytokine storm in critically ill patients COVID-19" provenance.
- OBJECT label "the effect of the ensuing cytokine storm in critically ill patients COVID-19" provenance.
- OBJECT label "the effect of the ensuing cytokine storm in critically ill patients COVID-19" provenance.
- OBJECT label "the effect of the ensuing cytokine storm in critically ill patients COVID-19" provenance.
- OBJECT label "the effect of the ensuing cytokine storm in critically ill patients COVID-19" provenance.
- OBJECT label "the effect of the ensuing cytokine storm in critically ill patients COVID-19" provenance.
- OBJECT label "the effect of the ensuing cytokine storm in critically ill patients COVID-19" provenance.
- OBJECT label "the effect of the ensuing cytokine storm in critically ill patients COVID-19" provenance.
- OBJECT label "the effect of the ensuing cytokine storm in critically ill patients COVID-19" provenance.
- OBJECT label "the effect of the ensuing cytokine storm in critically ill patients COVID-19" provenance.
- OBJECT label "the effect of the ensuing cytokine storm in critically ill patients COVID-19" provenance.
- OBJECT label "the effect of the ensuing cytokine storm in critically ill patients COVID-19" provenance.
- OBJECT label "the effect of the ensuing cytokine storm in critically ill patients COVID-19" provenance.
- OBJECT label "the effect of the ensuing cytokine storm in critically ill patients COVID-19" provenance.
- OBJECT label "the effect of the ensuing cytokine storm in critically ill patients COVID-19" provenance.
- OBJECT label "the effect of the ensuing cytokine storm in critically ill patients COVID-19" provenance.
- OBJECT label "the effect of the ensuing cytokine storm in critically ill patients COVID-19" provenance.
- OBJECT label "the effect of the ensuing cytokine storm in critically ill patients COVID-19" provenance.
- OBJECT label "glutathione , ascorbate , penicillin , streptomycin , and the appropriate secretagogue" provenance.
- OBJECT label "glutathione , ascorbate , penicillin , streptomycin , and the appropriate secretagogue" provenance.
- OBJECT label "glutathione , ascorbate , penicillin , streptomycin , and the appropriate secretagogue" provenance.
- OBJECT label "glutathione , ascorbate , penicillin , streptomycin , and the appropriate secretagogue" provenance.
- OBJECT label "glutathione , ascorbate , penicillin , streptomycin , and the appropriate secretagogue" provenance.
- OBJECT label "glutathione , ascorbate , penicillin , streptomycin , and the appropriate secretagogue" provenance.
- OBJECT label "glutathione , ascorbate , penicillin , streptomycin , and the appropriate secretagogue" provenance.
- OBJECT label "glutathione , ascorbate , penicillin , streptomycin , and the appropriate secretagogue" provenance.
- OBJECT label "glutathione , ascorbate , penicillin , streptomycin , and the appropriate secretagogue" provenance.
- OBJECT label "glutathione , ascorbate , penicillin , streptomycin , and the appropriate secretagogue" provenance.
- OBJECT label "glutathione , ascorbate , penicillin , streptomycin , and the appropriate secretagogue" provenance.
- OBJECT label "glutathione , ascorbate , penicillin , streptomycin , and the appropriate secretagogue" provenance.
- OBJECT label "glutathione , ascorbate , penicillin , streptomycin , and the appropriate secretagogue" provenance.
- OBJECT label "glutathione , ascorbate , penicillin , streptomycin , and the appropriate secretagogue" provenance.
- OBJECT label "glutathione , ascorbate , penicillin , streptomycin , and the appropriate secretagogue" provenance.
- OBJECT label "glutathione , ascorbate , penicillin , streptomycin , and the appropriate secretagogue" provenance.
- OBJECT label "glutathione , ascorbate , penicillin , streptomycin , and the appropriate secretagogue" provenance.
- OBJECT label "glutathione , ascorbate , penicillin , streptomycin , and the appropriate secretagogue" provenance.
- OBJECT label "glutathione , ascorbate , penicillin , streptomycin , and the appropriate secretagogue" provenance.
- OBJECT label "glutathione , ascorbate , penicillin , streptomycin , and the appropriate secretagogue" provenance.
- OBJECT label "glutathione , ascorbate , penicillin , streptomycin , and the appropriate secretagogue" provenance.
- OBJECT label "glutathione , ascorbate , penicillin , streptomycin , and the appropriate secretagogue" provenance.
- OBJECT label "glutathione , ascorbate , penicillin , streptomycin , and the appropriate secretagogue" provenance.
- OBJECT label "glutathione , ascorbate , penicillin , streptomycin , and the appropriate secretagogue" provenance.
- OBJECT label "glutathione , ascorbate , penicillin , streptomycin , and the appropriate secretagogue" provenance.
- OBJECT label "glutathione , ascorbate , penicillin , streptomycin , and the appropriate secretagogue" provenance.
- OBJECT label "glutathione , ascorbate , penicillin , streptomycin , and the appropriate secretagogue" provenance.
- OBJECT label "glutathione , ascorbate , penicillin , streptomycin , and the appropriate secretagogue" provenance.
- OBJECT label "glutathione , ascorbate , penicillin , streptomycin , and the appropriate secretagogue" provenance.
- OBJECT label "glutathione , ascorbate , penicillin , streptomycin , and the appropriate secretagogue" provenance.
- OBJECT label "mortality in severe cases" provenance.
- OBJECT label "mortality in severe cases" provenance.
- OBJECT label "mortality in severe cases" provenance.
- OBJECT label "that PGE2 and 5-iPF2α-VI can be a reliable biomarker of community oxidative anxiety" provenance.
- OBJECT label "that PGE2 and 5-iPF2α-VI can be a reliable biomarker of community oxidative anxiety" provenance.
- OBJECT label "that PGE2 and 5-iPF2α-VI can be a reliable biomarker of community oxidative anxiety" provenance.
- OBJECT label "that PGE2 and 5-iPF2α-VI can be a reliable biomarker of community oxidative anxiety" provenance.
- OBJECT label "that PGE2 and 5-iPF2α-VI can be a reliable biomarker of community oxidative anxiety" provenance.
- OBJECT label "that PGE2 and 5-iPF2α-VI can be a reliable biomarker of community oxidative anxiety" provenance.